Burning Rock Biotech Limited reported unaudited condensed earnings results for the first quarter ended March 31, 2021. For the period, the company reported revenues of RMB 106,623,000 against RMB 67,329,000 a year ago. Loss from operations was RMB 171,863,000 against RMB 59,342,000 a year ago. Net loss was RMB 171,411,000 against RMB 52,572,000 a year ago. Basic and diluted loss per class A ordinary shares was RMB 1.65. Basic and diluted loss per class B ordinary shares was RMB 1.65.